BVX001 - BiVictriX Therap
Blenrep (belantamab mafodotin-blmf) - GSK
Mylotarg (gemtuzumab ozogamicin) - Pfizer
https://ash.confex.com/ash/2024/webprogram/Paper198370.html
 
Mattia Vitale, PhD1; Hollie B S Griffiths, PhD2; Nyle Jones, PhD2; Meera Mistry, MSc(Eng)2; Jack Sangster, PhD2; Chloe Patterson, PhD2; Samuel E O'Halloran, PhD2; Adrian Blanco-Gomez, PhD2; Oliver Schon, PhD2; Tiffany Thorn (nee Daniels), MSc2
 
Nov 6, 2024
 
Next